Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep;24(9):1209-1226.
doi: 10.1007/s11886-022-01739-9. Epub 2022 Jun 29.

Tricuspid Valve Percutaneous Therapies

Bhaskar Bhardwaj  1 , Joaquin E Cigarroa  1 , Firas Zahr  2
Affiliations
Review

Tricuspid Valve Percutaneous Therapies

Bhaskar Bhardwaj et al. Curr Cardiol Rep. 2022 Sep.

Abstract

Purpose of review: In this review, we have focused on the currently available transcatheter tricuspid valve therapies, device selection, as well as role and management of tricuspid regurgitation (TR) in the setting of other transcatheter valvular procedures.

Recent findings: In this review, we have enlisted the recently finished as well as ongoing trials in the percutaneous tricuspid valve therapies. TR is highly prevalent yet remains underrecognized and is often untreated. TR has traditionally been managed conservatively with medical therapies including diuretics for volume management, whereas surgical therapies are reserved for those undergoing left-sided valvular surgery. Although the transcatheter devices for tricuspid repair and replacement are in clinical trials, the experience to date for their effectiveness and safety has been reassuring.

Keywords: Transcatheter tricuspid valve repair; Transcatheter tricuspid valve replacement; Tricuspid regurgitation.

PubMed Disclaimer

Similar articles

See all similar articles

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
    1. Topilsky Y, Maltais S, Medina Inojosa J, Oguz D, Michelena H, Maalouf J, et al. Burden of Tricuspid Regurgitation in Patients Diagnosed in the Community Setting. JACC Cardiovasc Imaging. 2019;12(3):433–42. - PubMed - DOI
    1. Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999;83(6):897–902. - PubMed - DOI
    1. Stuge O, Liddicoat J. Emerging opportunities for cardiac surgeons within structural heart disease. J Thorac Cardiovasc Surg. 2006;132(6):1258–61. - PubMed - DOI
    1. Zack CJ, Fender EA, Chandrashekar P, Reddy YNV, Bennett CE, Stulak JM, et al. National Trends and Outcomes in Isolated Tricuspid Valve Surgery. J Am Coll Cardiol. 2017;70(24):2953–60. - PubMed - DOI
    1. Dreyfus J, Ghalem N, Garbarz E, Cimadevilla C, Nataf P, Vahanian A, et al. Timing of Referral of Patients With Severe Isolated Tricuspid Valve Regurgitation to Surgeons (from a French Nationwide Database). Am J Cardiol. 2018;122(2):323–6. - PubMed - DOI

MeSH terms

LinkOut - more resources